Arora RK, Joseph A, Van Wyk J, et al. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard. Lancet Infect Dis. 2021;21:e75–6.

Article  CAS  PubMed  Google Scholar 

World Health Organization (WHO). Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. Available at: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic?adgroupsurvey=%7Badgroupsurvey%7D&gclid=EAIaIQobChMI4Ojtsdbe_gIVjQRyCh07igt4EAAYASACEgJ9pfD_BwE&fbclid=IwAR2M8EAyiSrAodhK9p-X582nHkP2AigpSX8pYIsLsPwqYh4SG26RGokGe7E. Accessed Jul 5, 2024.

Centers for Disease Control and Prevention. Underlying conditions and the higher risk for severe COVID-19. Available at: https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html. Accessed Jul 30, 2024.

Clark A, Jit M, Warren-Gash C, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8:e1003–17.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization (WHO). WHO roadmap on uses of COVID-19 vaccines in the context of Omicron and high population immunity. Available at: https://iris.who.int/bitstream/handle/10665/373987/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2023.2-eng.pdf?sequence=1. Accessed Jun 18, 2024.

Spikevax (mRNA-1273). Full prescribing information, Moderna, Inc., Cambridge, MA, 2022.

Comirnaty (BNT162b2). Full prescribing information, Pfizer/BioNTech, New York, NY, 2022.

Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–16.

Article  CAS  PubMed  Google Scholar 

Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–15.

Article  CAS  PubMed  Google Scholar 

Cari L, Naghavi Alhosseini M, Mencacci A, Migliorati G, Nocentini G. Differences in the expression levels of SARS-CoV-2 spike protein in cells treated with mRNA-based COVID-19 vaccines: a study on vaccines from the real world. Vaccines (Basel). 2023;11:879.

Article  CAS  PubMed  Google Scholar 

Zhang L, More KR, Ojha A, et al. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability. NPJ Vaccines. 2023;8:156.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kavikondala S, Haeussler K, Wang X, et al. Immunogenicity of mRNA-1273 and BNT162b2 in immunocompromised patients: systematic review and meta-analysis using GRADE. Infect Dis Ther. 2024;13:1419–38.

Article  PubMed  PubMed Central  Google Scholar 

Affeldt P, Koehler FC, Brensing KA, et al. Immune response to third and fourth COVID-19 vaccination in hemodialysis patients and kidney transplant recipients. Viruses. 2022;14:2646.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoeve CE, Huiberts AJ, de Gier B, et al. COVID-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study. Vaccine. 2024;42:126121.

Article  CAS  PubMed  Google Scholar 

Sieghart D, Hana CA, Durrschmid C, et al. Immunogenicity and safety of COVID-19 booster vaccination: a population-based clinical trial to identify the best vaccination strategy. J Clin Virol. 2024;173:105661.

Article  CAS  PubMed  Google Scholar 

Kavikondala S, Haeussler K, Wang X, et al. Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines among older adults: systematic literature review and meta-analysis using the GRADE framework. Infect Dis Ther. 2024;13:779–811.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Haeussler K, Spellman A, et al. Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework. Front Immunol. 2023;14:1204831.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nafziger AN, Pratt DS. Seasonal influenza vaccination and technologies. J Clin Pharmacol. 2014;54:719–31.

Article  CAS  PubMed  Google Scholar 

Centers for Disease Control and Prevention. CDC recommends updated 2024–2025 COVID-19 and flu vaccines for fall/winter virus season. Available at: https://www.cdc.gov/media/releases/2024/s-t0627-vaccine-recommendations.html. Accessed Jul 7, 2024.

US Food & Drug Administration. FDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants. US Food & Drug Administration. Available at: https://www.fda.gov/news-events/press-announcements/fda-takes-action-updated-mrna-covid-19-vaccines-better-protect-against-currently-circulating. Accessed Aug 28, 2024.

European Centre for Disease Prevention and Control. ECDC-EMA statement on updating COVID-19 vaccines composition for new SARS-CoV-2 virus variants. European Centre for Disease Prevention and Control. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-vaccines-composition-variants-statement-ECDC-EMA_0.pdf. Accessed Aug 28, 2024.

Bollaerts K, Wyndham-Thomas C, Miller E, et al. The role of real-world evidence for regulatory and public health decision-making for accelerated vaccine deployment—a meeting report. Biologicals. 2024;85:101750.

Article  PubMed  Google Scholar 

Schünemann H, Brożek J, Guyatt G, Oxman A, editors. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach: The GRADE Working Group; 2013.

U.S. Advisory Committee on Immunization Practices (ACIP) handbook for developting evidence-based reommendations: formulating questions, conducting the systematic review, and assessing the certainty of evidence using GRADE. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/vaccines/acip/recs/grade/downloads/ACIP-GRADE-Handbook_4-22-24.pdf. Accessed Jul 31, 2024.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Cai C, Peng Y, Shen E, et al. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Mol Ther. 2021;29:2794–805.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grana C, Ghosn L, Evrenoglou T, et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12:15477.

Google Scholar 

Kow CS, Hasan SS. Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies. Inflammopharmacology. 2021;29:1075–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee A, Wong SY, Chai LYA, et al. Efficacy of COVID-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 2022;376:e068632.

Article  PubMed  Google Scholar 

Sadeghi S, Kalantari Y, Shokri S, et al. Immunologic response, efficacy, and safety of vaccines against COVID-19 infection in healthy and immunosuppressed children and adolescents aged 2–21 years old: a systematic review and meta-analysis. J Clin Virol. 2022;153:105196.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu J, Lan X, Zhang L, et al. The effectiveness of the first dose COVID-19 booster vs. full vaccination to prevent SARS-CoV-2 infection and severe COVID-19 clinical event: a meta-analysis and systematic review of longitudinal studies. Front Public Health. 2023;11:1165611.

Article  PubMed  PubMed Central  Google Scholar 

Elzouki AY, Elshafei MN, Aziz A, et al. Seroconversion and safety of COVID-19 vaccines in patients with chronic liver disease and liver transplant: a systematic review. Qatar Med J. 2023;2023:21.

Article  PubMed  PubMed Central  Google Scholar 

Adams K, Rhoads JP, Surie D, et al. Vaccine effectiveness of primary series and booster doses against COVID-19 associated hospital admissions in the United States: living test negative design study. BMJ. 2022;379:e072065.

Article  PubMed  Google Scholar 

Li Z, Hu Y, Zou B. The vaccine-response in patients with cirrhosis after COVID-19 vaccination: a systematic analysis of 168,245 patients with cirrhosis. J Hepatol. 2023;79:e157–62.

Article  PubMed  Google Scholar 

Ribeiro TB, Roque F, Ida F, et al. Early real-world data to assess benefits and risks of COVID-19 vaccines: a systematic review of methods. Vaccines (Basel). 2022;10:85.

Google Scholar 

Petras M, Macalik R, Janovska D, et al. Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression. BMC Med. 2022;20:461.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahmani K, Shavaleh R, Forouhi M, et al. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: a systematic review and meta-analysis. Front Public Health. 2022;10:873596.

Article  PubMed  PubMed Central  Google Scholar 

Widhani A, Hasibuan AS, Rismawati R, et al. Efficacy, immunogenicity, and safety of COVID-19 vaccines in patients with autoimmune diseases: a systematic review and meta-analysis. Vaccines (Basel). 2023;11:1456.

Article